Paraneoplastic AutoAb Evaluation (Sendout)
General Information
- Lab Name
- Paraneoplastic Autoantibody Evaluation, Serum (Sendout)
- Lab Code
- RPNPV
- Epic Ordering
- Paraneoplastic Autoantibody Evaluation, Serum (Sendout)
- External Test Id
- PAVAL
- Description
Useful For:
- Serological evaluation of patients who present with a subacute neurological disorder of undetermined etiology, especially those with known risk factors for cancer
- Directing a focused search for cancer
- Investigating neurological symptoms that appear in the course of, or after, cancer therapy, and are not explainable by metastasis
- Differentiating autoimmune neuropathies from neurotoxic effects of chemotherapy
- Monitoring the immune response of seropositive patients in the course of cancer therapy
- Detecting early evidence of cancer recurrence in previously seropositive patients
For a complete list of tests and potential reflex tests included in this panel, refer to Mayo's algorithm linked below.
Ordering Note: Individual antibody tests within the Paraneoplastic Autoantibody Evaluation are available for patients who have previously tested positive for those antibodies within the past five years at a Mayo laboratory. Refer to Mayo test: Neuroimmunology Antibody Follow-up, Serum.
- Synonyms
- AGNA-1, Amphiphysin Ab, ANNA-1, ANNA-2, ANNA-3, Anti Glial Nuclear Ab 1, Anti Neuronal Nuclear Ab 1, Anti Neuronal Nuclear Ab 2, Anti Neuronal Nuclear Ab 3, CRMP-5 IgG, P/Q Type Calcium Channel Ab, PAVAL, PCA-1, PCA-2, PCA-Tr, Purkinje Cell Cytoplasmic Ab Type 1, Purkinje Cell Cytoplasmic Ab Type 2, Purkinje Cell Cytoplasmic Ab Type Tr
- Components
-
Code Name RPNPEV Paraneoplastic AutoAb Evaluation (Sendout) RANN1 Anti Neuronal Nuclear Antibody 1 RANN2 Anti Neuronal Nuclear Antibody 2 RANN3 Anti Neuronal Nuclear Antibody 3 RAGNA1 Anti Glial Nuclear Antibody 1 RPCA1 Purkinje Cell Cytoplasmic Antibody 1 RPCA2 Purkinje Cell Cytoplasmic Antibody 2 RPCATR Purkinje Cell Cytoplasmic Antibody Tr RAMPHS Amphiphysin Antibody RCRMP CRMP 5 IgG RCCPQ P/Q Type Calcium Channel Ab RNVGCK Neuronal (V_G) K Channel Ab RPNINT Paraneoplastic AutoAb Interp UW437 UW Imm_Study Paraneoplastic AutoAb
Interpretation
- Method
Panel Tests:
- Indirect Immunofluorescence Assay (IFA): Amphiphysin Ab, Anti-Glial Nuclear Ab Type 1,
Anti-Neuronal Nuclear Ab Type 1, Anti-Neuronal Nuclear Ab Type 2, Anti-Neuronal Nuclear Ab Type 3, CRMP-5-IgG, Purkinje Cell Cytoplasmic Ab Type 1, Purkinje Cell Cytoplasmic Ab Type 2, Purkinje Cell Cytoplasmic Ab Type Tr. - Radioimmunoassay (RIA): Neuronal (V-G) K+ Channel Ab, P/Q-Type Calcium Channel Ab.
Reflex Tests:
- Indirect Immunofluorescence Assay (IFA): AGNA-1 Titer, Amphiphysin Ab Titer, ANNA-1 Titer, ANNA-3 Titer, CRMP-5-IgG Titer, PCA-1 Titer, PCA-2 Titer, PCA-Tr Titer, ANNA-2 Titer.
- Western Blot (WB): CRMP-5-IgG Western Blot.
- Immunoblot (IB): AGNA-1 Immunoblot, Amphiphysin Immunoblot, ANNA-1 Immunoblot, ANNA-2 Immunoblot, PCA-1 Immunoblot, PCA-Tr Immunoblot.
- Cell-Binding Assay (CBA): CASPR2-IgG CBA, LGI1-IgG CBA.
- Indirect Immunofluorescence Assay (IFA): Amphiphysin Ab, Anti-Glial Nuclear Ab Type 1,
- Reference Range
- See individual components
- Ref. Range Notes
Reference Ranges:
(Panel tests only)
Amphiphysin Ab, Serum Negative AGNA-1, Serum Negative ANNA-1, Serum Negative ANNA-2, Serum Negative ANNA-3, Serum Negative CRMP-5-IgG, Serum Negative Neuronal (V-G) K+ Channel Ab, Serum < or =0.02 nmol/L P/Q-Type Calcium Channel Ab, Serum < or =0.02 nmol/L PCA-1, Serum Negative PCA-2, Serum Negative PCA-Tr, Serum Negative Interpretation: Antibodies directed at onconeural proteins shared by neurons, glia, muscle, and certain cancers are valuable serological markers of a patient's immune response to cancer. They are not found in healthy subjects and are usually accompanied by subacute neurological symptoms and signs. Several autoantibodies have a syndromic association, but no autoantibody predicts a specific neurological syndrome. Conversely, a positive autoantibody profile has 80% to 90% predictive value for a specific cancer. It is not uncommon for more than one paraneoplastic autoantibody to be detected, each predictive of the same cancer.
- Guidelines
Ordering & Collection
- Specimen Type
- Blood
- Collection
-
12 mL blood in RED TOP tubes or GOLD SSTs
- Handling Instructions
Outside Laboratories: Centrifuge sample and transfer serum into a separate plastic vial. Refrigerate serum.
Stability: Refrigerated (preferred): 28 days; Frozen: 28 days; Ambient: 72 hours.
Reject Due To: Gross hemolysis, lipemia, icterus.
- Quantity
-
requested: 4 mL serum + 1 mL for UW437
minimum: 2 mL serum
Processing
- Processing
Centrifuge samples. If specimen volume allows, aliquot 1mL serum into a separate plastic vial for Immunology (UW437) and the remaining serum into a plastic vial for the Sendout test (RPNPEV). Prioritize the Sendout test.
- RPNPEV: Refrigerate serum.
- UW437: Freeze serum at -20°C.
If individual antibodies are requested (with a previous positive result within the last 5 years at Mayo), refer to separate test guide #982 (Neuroimmunology Follow-up, PNEFS).
Sendouts:
- Order Mayo Test: PAVAL.
Stability: Refrigerated (preferred): 28 days; Frozen: 28 days; Ambient: 72 hours.
Reject Due To: Gross hemolysis, lipemia, icterus.
Performance
- LIS Dept Code
- Performing Location(s)
-
Sendout Mayo Clinic Laboratories
800-533-1710200 First Street Southwest
Rochester, MN 55901 - Frequency
- Performed: Monday - Sunday. Reflex tests: Varies. Report Available: 10-17 days.
- Available STAT?
- No
Billing & Coding
- CPT codes
- 83519, 86256x9, 86596
- LOINC
- 43104-9
- Interfaced Order Code
- UOW3348